Stoke Therapeutics, Inc.STOKNASDAQ
Loading
Stockholders Equity Over TimeExpanding
Percentile Rank100
3Y CAGR+24.0%
5Y CAGR+4.3%
Year-over-Year Change
Net worth of the company (assets minus liabilities)
3Y CAGR
+24.0%/yr
vs +15.2%/yr prior
5Y CAGR
+4.3%/yr
Recent acceleration
Acceleration
+8.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $352.46M | +53.9% |
| 2024 | $229.02M | +43.5% |
| 2023 | $159.56M | -13.7% |
| 2022 | $184.85M | -15.1% |
| 2021 | $217.78M | -23.9% |
| 2020 | $286.08M | +27.5% |
| 2019 | $224.43M | +113.6% |
| 2018 | $105.07M | +8232.2% |
| 2017 | $-1.29M | - |